Literature DB >> 20238110

Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction.

Hiroshi Nishioka1, Makoto Shibuya, Kuninori Ohtsuka, Yukio Ikeda, Jo Haraoka.   

Abstract

INTRODUCTION: The study aims to describe the endocrinological and magnetic resonance imaging (MRI) features of the rarely reported xanthogranulomas associated with pituitary adenoma.
METHODS: Of 231 consecutive pituitary adenomas treated surgically, those with xanthogranulomatous reaction on histology were reviewed.
RESULTS: Five patients (2.2%) had an adenoma with marked xanthogranulomatous reaction. They were all nonfunctioning macroadenomas and presented with anterior pituitary insufficiencies. On MRI, all adenomas showed mixed signal intensities on T1- and T2-weighted images with heterogeneous gadolinium enhancement, reflecting their complex histological features: Cholesterol clefts typically showed T1 high- and T2 low-signal intensities. Preoperative diagnosis was difficult in a case predominantly featuring xanthogranuloma. Although none of them had episodes of pituitary apoplexy, hemosiderin deposits and cysts with xanthochromic-like fluid were observed in five and four cases, respectively.
CONCLUSIONS: Xanthogranulomatous reaction may develop in macroadenomas, probably triggered by hemorrhagic processes despite no apoplectic episodes. They typically exhibit complex mixed signal intensity on MRI, particularly T1 high- and T2 low-signal intensities, and patients present with pituitary dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238110     DOI: 10.1007/s00234-010-0675-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Magnetic resonance imaging, clinical manifestations, and management of Rathke's cleft cyst.

Authors:  Hiroshi Nishioka; Jo Haraoka; Hitoshi Izawa; Yukio Ikeda
Journal:  Clin Endocrinol (Oxf)       Date:  2006-02       Impact factor: 3.478

2.  Xanthogranuloma of the sellar region.

Authors:  C S Jung; A Schänzer; E Hattingen; K H Plate; V Seifert
Journal:  Acta Neurochir (Wien)       Date:  2005-12-12       Impact factor: 2.216

3.  Xanthogranuloma and xanthoma of the choroid plexus: evidence for different etiology and pathogenesis.

Authors:  A Muenchau; R Laas
Journal:  Clin Neuropathol       Date:  1997 Mar-Apr       Impact factor: 1.368

4.  Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma.

Authors:  W Paulus; J Honegger; K Keyvani; R Fahlbusch
Journal:  Acta Neuropathol       Date:  1999-04       Impact factor: 17.088

5.  Xanthogranulomatous hypophysitis mimicking a pituitary neoplasm.

Authors:  Shunichi Yokoyama; Toshiaki Sano; Kenichiro Tajitsu; Kazuhiro Kusumoto
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

6.  [Histopathological study of the "cholesterol granuloma reaction" in the sellar and juxta-sellar tumors].

Authors:  K Shirataki; S Okada; S Matsumoto
Journal:  No To Shinkei       Date:  1988-02

Review 7.  Xanthomatous pituitary lesions: a report of two cases and review of the literature.

Authors:  Morton G Burt; Adrienne L Morey; Jenny J Turner; Malcolm Pell; John P Sheehy; Ken K Y Ho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

8.  Xanthogranuloma in the suprasellar region.

Authors:  Sei Sugata; Hirofumi Hirano; Kazutaka Yatsushiro; Shunji Yunoue; Katsumi Nakamura; Kazunori Arita
Journal:  Neurol Med Chir (Tokyo)       Date:  2009-03       Impact factor: 1.742

9.  Granulomatous hypophysistis associated with rathke's cleft cyst: a case report.

Authors:  M Murakami; H Nishioka; H Izawa; Y Ikeda; J Haraoka
Journal:  Minim Invasive Neurosurg       Date:  2008-06

10.  Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases.

Authors:  Takashi Tashiro; Toshiaki Sano; Bing Xu; Shing Wakatsuki; Noriko Kagawa; Hroshi Nishioka; Shozo Yamada; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2002       Impact factor: 4.056

View more
  7 in total

1.  Immunohistochemical study for IgG4-positive plasmacytes in pituitary inflammatory lesions.

Authors:  Hiroshi Nishioka; Makoto Shibuya; Jo Haraoka
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Xanthogranulomatous pituitary adenoma: A case report and literature review.

Authors:  Guihong Li; Chaochao Zhang; Yuxue Sun; Qingchun Mu; Haiyan Huang
Journal:  Mol Clin Oncol       Date:  2018-01-10

3.  FROM DIABETES INSIPIDUS TO SELLAR XANTHOGRANULOMA - A "YELLOW BRICK ROAD" DEMANDING TEAM-WORK.

Authors:  M Stojanovic; E Manojlovic-Gacic; S Pekic; T Milojevic; D Miljic; M Doknic; M Nikolic Djurovic; Z Jemuovic; M Petakov
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

4.  Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report.

Authors:  Takamasa Nishiuchi; Koji Murao; Hitomi Imachi; Yoshio Kushida; Reiji Haba; Nobuyuki Kawai; Takashi Tamiya; Toshihiko Ishida
Journal:  J Med Case Rep       Date:  2012-04-29

5.  Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.

Authors:  R Ved; N Logier; P Leach; J S Davies; C Hayhurst
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 6.  Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare Inflammatory Entity.

Authors:  Vera Lozovanu; Carmen Emanuela Georgescu; Lavinia Maria Florescu; Carmen Georgiu; Horatiu Silaghi; Andrian Fratea; Cristina Alina Silaghi
Journal:  J Pers Med       Date:  2022-06-08

7.  Xanthogranulomatous hypophysitis: a rare and often mistaken pituitary lesion.

Authors:  Jaya Sujatha Gopal-Kothandapani; Veejay Bagga; Stephen B Wharton; Daniel J Connolly; Saurabh Sinha; Paul J Dimitri
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.